The Foundation also awarded Continuation Grants to three Damon Runyon Clinical Investigators, totaling $1,000,000 in additional funding. The Continuation Grants are designed to support Clinical ...

Clinical study in Scientific Reports shows Bridge CaptureTM detects key mutations from blood samples in metastatic colorectal cancer patients ...

Genomill Health, a biotechnology company pioneering simplified targeted library preparation for next-generation sequencing ...

A novel artificial intelligence (AI) application capable of diagnosing endocrine cancers with speed and accuracy is being ...

Kenya’s fight against cancer has entered a new phase, driven by technological breakthroughs that promise to transform diagnosis, treatment, and survival rates.

DixonBaxi has created the new look for C the Signs, which utilises AI and real-time clinical data to reimagine the process of cancer detection and diagnosis ...

The update strengthens IBTROZI's position as a next-generation treatment in a rare, aggressive lung cancer that often spreads ...

Human resources executive Jane Elliott, physician Brenda Haynes, and entrepreneur Chance Wright have been named to RIT’s ...

Werewolf Therapeutics, Inc. (the 'Company” or 'Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...

Adcentrx Therapeutics ("Adcentrx"), a clinical-stage biotechnology company redefining Antibody-Drug Conjugate (ADC) therapies for cancer treatment and other life-threatening diseases, today announced ...

A breakthrough in cancer therapy: metal-phenolic nanocarriers deliver antibodies directly to cancer cells, improving treatment efficacy and reducing toxicity.